Pediatric Supplement Controls

Pediatric supplement controls cover the formulation, packaging, labelling and pharmacovigilance posture for infant, toddler, child and adolescent supplements. The discipline begins with age-band-specific RDA and UL — vitamin D UL ranges from 1000 IU/day for 0-6 months to 4000 IU/day for 9-18 years; vitamin A UL from 600 µg RAE/day for 1-3 years to 1700 µg/day for 9-13 years; iron UL 40 mg/day for 0-13 years; zinc UL 7 mg/day for 1-3 years to 23 mg/day for 9-13 years. Gummy formats compound dose risk through self-administered overconsumption — the FDA pediatric supplement poison-control profile is dominated by iron, vitamin D and gummy overdose. Iron overdose drives the 21 CFR 101.17(e) warning ('WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6...') and unit-dose packaging requirement at the 30 mg per serving trigger, with analogous expectation in pediatric SKUs below the formal trigger due to lower body weight. Choking hazard in gummy and chewable formats requires under-4 contraindication or dosage-form engineering against pediatric choking criteria. Child-resistant packaging per 16 CFR 1700 Poison Prevention Packaging Act applies to iron-containing products at the 250 mg total iron per package trigger and is voluntarily extended to pediatric SKUs with foreseeable overdose risk. Sweetener and added-sugar specifications align to American Academy of Pediatrics guidance (<25 g added sugar/day for 2-18 years, avoidance below 2). Big-9 allergen management is elevated due to higher pediatric anaphylaxis severity. Every pediatric AER is treated as elevated-risk with accelerated triage and built-in cluster detection.